A Phase 1/2 Study Evaluating the Safety and Efficacy of IOV-2001 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Administered By

Awarded By

Contributors

Start/End

  • October 26, 2021 - October 31, 2026